Millennium Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.39M Sell
401,819
-537,556
-57% -$11.7M ﹤0.01% 2669
2025
Q4
$24.7M Sell
939,375
-529,469
-36% -$13.7M 0.01% 1371
2025
Q3
$33.2M Buy
1,468,844
+26,582
+2% +$547K 0.01% 1177
2025
Q2
$28.7M Sell
1,442,262
-527,171
-27% -$10.3M 0.01% 1241
2025
Q1
$33.3M Buy
1,969,433
+437,632
+29% +$7.45M 0.02% 1074
2024
Q4
$28.3M Buy
1,531,801
+261,152
+21% +$5.1M 0.01% 1224
2024
Q3
$27.6M Buy
1,270,649
+311,797
+33% +$6.97M 0.01% 1269
2024
Q2
$18.8M Buy
958,852
+244,981
+34% +$5.11M 0.01% 1553
2024
Q1
$15.5M Buy
713,871
+349,143
+96% +$8.67M 0.01% 1768
2023
Q4
$10.5M Buy
364,728
+333,299
+1,060% +$8.92M ﹤0.01% 2132
2023
Q3
$840K Buy
31,429
+5,622
+22% +$192K ﹤0.01% 4301
2023
Q2
$956K Sell
25,807
-25,820
-50% -$900K ﹤0.01% 4078
2023
Q1
$1.61M Buy
51,627
+21,259
+70% +$684K ﹤0.01% 3640
2022
Q4
$904K Sell
30,368
-92,100
-75% -$3.3M ﹤0.01% 4267
2022
Q3
$4.67M Buy
122,468
+72,893
+147% +$3.65M ﹤0.01% 2954
2022
Q2
$2.7M Sell
49,575
-231,361
-82% -$12.7M ﹤0.01% 3398
2022
Q1
$17.5M Buy
280,936
+278,201
+10,172% +$18.3M 0.01% 1531
2021
Q4
$275K Sell
2,735
-6,803
-71% -$598K ﹤0.01% 5633
2021
Q3
$858K Sell
9,538
-5,031
-35% -$457K ﹤0.01% 4848
2021
Q2
$1.34M Sell
14,569
-62,031
-81% -$4.95M ﹤0.01% 4381
2021
Q1
$7.4M Buy
76,600
+17,982
+31% +$1.86M 0.01% 2128
2020
Q4
$3.05M Sell
58,618
-24,897
-30% -$1.04M ﹤0.01% 2882
2020
Q3
$3.34K Sell
83,515
-16,255
-16% -$509K ﹤0.01% 2182
2020
Q2
$1.6M Buy
99,770
+51,207
+105% +$784K ﹤0.01% 2689
2020
Q1
$523K Buy
+48,563
New +$676K ﹤0.01% 2851
2017
Q3
Sell
-14,619
Closed -$93K 3611
2017
Q2
$93K Buy
14,619
+3,625
+33% +$29.2K ﹤0.01% 3306
2017
Q1
$120K Sell
10,994
-12,207
-53% -$144K ﹤0.01% 3302
2016
Q4
$268K Sell
23,201
-65,313
-74% -$616K ﹤0.01% 2957
2016
Q3
$816K Buy
+88,514
New +$814K ﹤0.01% 2374

Other funds holding FLGT

Millennium Management's FLGT Position: Q1 2026 in Review

Millennium Management reduced its Fulgent Genetics (FLGT) stake by 57% in Q1 2026, selling an estimated $11.7M and leaving 401,819 shares worth $6.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2669.

Millennium Management first reported a position in FLGT in Q3 2016 and has held it in 29 quarters since. The position peaked at $33.3M in Q1 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Millennium Management held 401,819 shares of Fulgent Genetics worth $6.39M as of Q1 2026.
  • Millennium Management sold 537,556 Fulgent Genetics shares in Q1 2026, an estimated $11.7M.
  • Fulgent Genetics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2669 holding.
  • Millennium Management first reported a position in Fulgent Genetics in Q3 2016 and has held it in 29 quarters since.
  • Millennium Management's Fulgent Genetics position peaked at $33.3M in Q1 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.